Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B‐cell non‐Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|123|7|413-420

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.123, Iss.7, 2015-07, pp. : 413-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma

By  

Cytogenetic and Genome Research, Vol. 118, Iss. 2-4, 2007-11 ,pp. : 345-352

Karger

Access to resources Recommend Favorite

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 285-287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Derangement of the T‐cell repertoire in patients with B‐cell non‐Hodgkin's lymphoma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 4, 2015-04 ,pp. : 298-309

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B‐cell non‐Hodgkin lymphoma: A Wisconsin Oncology Network study

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3465-3471

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological features of double‐hit B‐cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 10, 2015-10 ,pp. : 519-527

John Wiley & Sons Inc

Access to resources Recommend Favorite